Serigen Mediproducts (Formerly BiolMed Innovations)

Serigen Mediproducts, formerly BiolMed Innovations, is a biomedical products company specializing in tissue regeneration using natural silk proteins. It was founded in 2015 by Dr. Anuya Nisal, Dr. Swati Shukla, and Dr. Premnath Venugopalan as a spin-off from the CSIR-National Chemical Laboratory in Pune, India. The founders' vision was to leverage India's position as the second-largest global silk producer to address the country's reliance on imported medical devices. Dr. Nisal's background in Material Science and her PhD research on silk's medical applications were foundational to the company's creation.

The company develops and manufactures products for orthopedics, advanced wound care, and soft tissue repair. Its business model is primarily B2B, serving hospitals and medical professionals. Serigen's core technology involves patented protocols to process silk threads into various forms suitable for biomedical applications, with patents granted in the US, Europe, Japan, and India. The company operates an ISO 13485-certified manufacturing facility and has received regulatory approval from India's CDSCO for its wound care product.

Serigen's product line includes: 'Seriderm', a silk-based wound dressing for complex wounds like diabetic foot ulcers and burns; 'Serioss', an osteoconductive bone void filler; and 'Serimat', a silk protein matrix for soft tissue regeneration in procedures like breast reconstruction and abdominal wall repair. Serigen was the first company in the world to conduct a human clinical trial demonstrating the utility of silk-based scaffolds for bone repair. The company has raised capital through several funding rounds to support clinical trials, secure global regulatory approvals, and scale its sales and marketing efforts.

Keywords: tissue regeneration, silk protein, biomedical devices, wound care, orthopedics, bone void filler, soft tissue repair, medical technology, sericulture, biomaterials, surgical mesh, advanced dressings, reconstructive surgery, medical devices, ISO 13485, CDSCO approval, clinical trials, polymer science, material science, medtech, biotechnology